Literature DB >> 24639380

Improved immunoblotting methods provide critical insights into phenotypic differences between two murine dysferlinopathy models.

Amber L Mueller1, Patrick F Desmond, Ru-Ching Hsia, Joseph A Roche.   

Abstract

INTRODUCTION: We adopted a proteomics-based approach to gain insights into phenotypic differences between A/J and B10.SJL murine dysferlinopathy models.
METHODS: We optimized immunoblotting of dysferlin by preparing homogenates of the tibialis anterior (TA) muscle under several different conditions. We compared TA muscles of control, A/J, and B10.SJL mice for levels of dysferlin; dysferlin's partners MG53, annexin-A2, and caveolin-3; and the endoplasmic reticulum (ER) stress marker CHOP. We performed immunoelectron microscopy on control rat TA muscle to determine the precise location of dysferlin.
RESULTS: RIPA (radioimmunoprecipitation assay) buffer and sonication improves immunoblotting of dysferlin. The ER stress marker CHOP is elevated in A/J muscle. Dysferlin is localized mostly to membranes close to the Z-disk that have been reported to be part of the Golgi, ER, and sarcoplasmic reticulum (SR) networks.
CONCLUSIONS: ER stress might underlie phenotypic differences between A/J and B10.SJL mice and play a role in human dysferlinopathies.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ER stress; dysferlin; dysferlin binding proteins; immunoblotting; skeletal muscle

Mesh:

Substances:

Year:  2014        PMID: 24639380      PMCID: PMC4107149          DOI: 10.1002/mus.24220

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  14 in total

1.  Distribution of the endoplasmic reticulum and its relationship with the sarcoplasmic reticulum in skeletal myofibers.

Authors:  Tuula Kaisto; Kalervo Metsikkö
Journal:  Exp Cell Res       Date:  2003-09-10       Impact factor: 3.905

2.  Modification of Unicryl composition for rapid polymerization at low temperature without alteration of immunocytochemical sensitivity.

Authors:  P Gounon; J P Rolland
Journal:  Micron       Date:  1998-08       Impact factor: 2.251

3.  Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.

Authors:  Bàrbara Flix; Carolina de la Torre; Juan Castillo; Carme Casal; Isabel Illa; Eduard Gallardo
Journal:  Int J Biochem Cell Biol       Date:  2013-06-19       Impact factor: 5.085

4.  Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).

Authors:  Eriko Fujita; Yoriko Kouroku; Atsushi Isoai; Hiromichi Kumagai; Akifumi Misutani; Chie Matsuda; Yukiko K Hayashi; Takashi Momoi
Journal:  Hum Mol Genet       Date:  2007-03-01       Impact factor: 6.150

5.  Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Authors:  Mengfatt Ho; Cristina M Post; Leah R Donahue; Hart G W Lidov; Roderick T Bronson; Holly Goolsby; Simon C Watkins; Gregory A Cox; Robert H Brown
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

6.  MG53 nucleates assembly of cell membrane repair machinery.

Authors:  Chuanxi Cai; Haruko Masumiya; Noah Weisleder; Noriyuki Matsuda; Miyuki Nishi; Moonsun Hwang; Jae-Kyun Ko; Peihui Lin; Angela Thornton; Xiaoli Zhao; Zui Pan; Shinji Komazaki; Marco Brotto; Hiroshi Takeshima; Jianjie Ma
Journal:  Nat Cell Biol       Date:  2008-11-30       Impact factor: 28.824

7.  Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing.

Authors:  Niall J Lennon; Alvin Kho; Brian J Bacskai; Sarah L Perlmutter; Bradley T Hyman; Robert H Brown
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

Review 8.  Dysferlinopathies.

Authors:  J Andoni Urtizberea; Guillaume Bassez; France Leturcq; Karine Nguyen; Martin Krahn; Nicolas Levy
Journal:  Neurol India       Date:  2008 Jul-Sep       Impact factor: 2.117

9.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B.

Authors:  R Bashir; S Britton; T Strachan; S Keers; E Vafiadaki; M Lako; I Richard; S Marchand; N Bourg; Z Argov; M Sadeh; I Mahjneh; G Marconi; M R Passos-Bueno; E de S Moreira; M Zatz; J S Beckmann; K Bushby
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

10.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.

Authors:  J Liu; M Aoki; I Illa; C Wu; M Fardeau; C Angelini; C Serrano; J A Urtizberea; F Hentati; M B Hamida; S Bohlega; E J Culper; A A Amato; K Bossie; J Oeltjen; K Bejaoui; D McKenna-Yasek; B A Hosler; E Schurr; K Arahata; P J de Jong; R H Brown
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

View more
  4 in total

1.  Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle.

Authors:  Joseph A Roche; Mohan E Tulapurkar; Amber L Mueller; Nico van Rooijen; Jeffrey D Hasday; Richard M Lovering; Robert J Bloch
Journal:  Am J Pathol       Date:  2015-04-25       Impact factor: 4.307

2.  Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair.

Authors:  G M I Redpath; N Woolger; A K Piper; F A Lemckert; A Lek; P A Greer; K N North; S T Cooper
Journal:  Mol Biol Cell       Date:  2014-08-20       Impact factor: 4.138

3.  Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B.

Authors:  Zoe White; Nadia Milad; Arash Y Tehrani; William Wei-Han Chen; Graham Donen; Stephanie L Sellers; Pascal Bernatchez
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

4.  Pseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.

Authors:  Joshua E Mangum; Justin P Hardee; Dennis K Fix; Melissa J Puppa; Johnathon Elkes; Diego Altomare; Yelena Bykhovskaya; Dean R Campagna; Paul J Schmidt; Anoop K Sendamarai; Hart G W Lidov; Shayne C Barlow; Nathan Fischel-Ghodsian; Mark D Fleming; James A Carson; Jeffrey R Patton
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.